Treatment with Metformin Can Improve Insulin Resistance and Lipid Profile in Non-Diabetic Iraqi Women with Polycystic Ovary Syndrome
Background: Women with polycystic ovary syndrome (PCOS) are usually at increased risk of metabolic syndrome and insulin resistance (IR), regardless of their body weight, and the development of type 2 diabetes in those women is not uncommon. Metformin is an oral hypoglycemic drug with a significant r...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-10-01
|
| Series: | Medical Journal of Babylon |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/MJBL.MJBL_913_23 |